HPLC Purity and LC-MS Identity Answer Two Different Questions

Almost every peptide certificate of analysis carries two headline results: a purity percentage from HPLC and a mass number from mass spectrometry. They look like two versions of the same reassurance. They are not. They answer different questions, they fail in different ways, and reading one as though it covered the other is the most common mistake people make with these documents.

The short answer#

HPLC purity is a ratio. It asks: of the material the detector saw, what share was the main peak? That is what a figure like "99.4% by HPLC" is.

Mass spectrometry identity is a match. It asks: does the main peak weigh what this sequence should weigh? That is a yes-or-no question about which molecule you have.

A batch can pass one and fail the other. High purity with the wrong molecule means a very clean sample of something else. Correct identity with low purity means the right molecule surrounded by other things. Only running both narrows it down, and even then some questions remain open.

What an HPLC purity number is actually counting#

The standard purity method is reversed-phase liquid chromatography with an ultraviolet detector. The mixture is pushed through a column that separates its components by how strongly they stick, and a lamp watches the stream as things come off. The detector usually looks at around 210–220 nm, where the peptide bond itself absorbs.

The instrument records a trace with peaks. Software integrates the area under each peak. Purity is reported as the main peak's area divided by the total area of all peaks.

Three consequences follow directly, and none of them is a defect. They are just what the measurement is.

It only counts what the detector sees. A substance that does not absorb at that wavelength produces no peak. It is not in the numerator and it is not in the denominator. Counterions, water and many inorganic salts fall into this category. They cannot reduce a purity figure because the measurement never registers them.

It only counts what comes off the column. Anything that sticks permanently, or never dissolves in the first place, is not part of the ratio either.

Area is not mass. The method treats absorbance as a proxy for amount, and that is only roughly true. Kuipers and Gruppen measured the ultraviolet absorbance of all twenty amino acids and the peptide bond at 214 nm. The peptide bond came in at 923 M⁻¹cm⁻¹. Tryptophan absorbed about thirty times more than a peptide bond; phenylalanine, tyrosine and histidine about six times more^[1].

Read what that implies. Two peptides of the same size can produce quite different peak areas for the same number of molecules, purely because of which amino acids they contain. An impurity that happens to carry an extra tryptophan looks bigger than it is. One that has lost a tryptophan looks smaller. Area percent is a useful, standardised comparison. It is not a mass balance.

What mass spectrometry adds#

A mass spectrometer does not look at the sample with light. It ionises molecules and measures their mass-to-charge ratio. For a peptide, the sequence predicts a molecular weight. If the observed mass matches the prediction, the molecule is consistent with the sequence claimed.

That is an identity test, and it is the test a purity assay cannot perform. A chromatogram with one tall, clean peak tells you the sample is homogeneous. It does not tell you the peak is the peptide you ordered.

Running the mass detector in line with the chromatograph adds a second, more subtle capability: it assigns a mass to each point in the trace. That is what exposes co-elution — two different substances leaving the column at the same time and merging into one apparent peak. In an ultraviolet-only trace, that peak looks single and clean. With mass detection, two masses appear where there should be one.

Manufacturer quality-control documentation treats purity, identity and content as separate line items in a release panel for exactly this reason^[6]. They are not redundant. They are three different questions.

What actually shows up in a synthetic peptide#

Solid-phase synthesis builds a chain one residue at a time, and every step has a small failure rate. The by-products are well characterised.

A 2025 analysis examined commercially produced peptide pools using ultra-high-performance chromatography with high-resolution mass spectrometry, reading the ultraviolet chromatograms and the mass spectra together. The impurity classes it identified were^[3]:

• Dimers, formed when free cysteine residues on two chains bond to each other — the most frequent finding, and the authors note it was somewhat unexpected
• Pyroglutamate formation at an N-terminal glutamine or glutamate
• Aspartimide formation, a ring closure at aspartic acid
• Deamidation, which converts asparagine or glutamine and shifts the mass by about one dalton
• Methionine oxidation, which adds an oxygen
• Amino-acid deletions, where a residue is simply missing from the chain

Most of what they found was present in trace amounts and, in their judgement, unimportant for the intended use.

Notice what the list has in common. A deletion changes the mass a lot and usually changes the retention time. Oxidation adds 16 daltons. Deamidation shifts the mass by roughly 0.98 daltons — a difference small enough that ordinary mass resolution can miss it, which is why the work used high-resolution instruments. Each of these needs a specific kind of look to be found at all.

The impurity that mass spectrometry cannot catch#

There is one category that defeats a mass measurement completely.

During synthesis, an amino acid can racemise — flip from the natural L form to the mirror-image D form. Palasek and colleagues identified cysteine, histidine and aspartic acid as the residues most prone to this in microwave-assisted Fmoc synthesis, and showed the rate depends heavily on conditions: dropping the coupling temperature from 80 °C to 50 °C limited racemisation of histidine and cysteine, and changes to the deprotection chemistry reduced aspartimide formation and the racemisation that follows from it^[2].

Here is why this matters for reading a certificate. A peptide with one racemised residue has exactly the same molecular formula as the correct peptide. Same atoms, same mass, same mass spectrum. A mass spectrometer cannot distinguish them, because there is nothing in the mass to distinguish.

Chromatography sometimes can, because the two forms are shaped differently and may stick to the column differently — they may appear as a shoulder or a second peak. Sometimes they do not separate at all. Detecting racemisation reliably takes a method built for it, such as chiral analysis after hydrolysis.

Putting the two side by side#

What regulated manufacturing does differently#

Approved drug products are released against a specification: identity, purity, individual impurities, content, water and residual solvents are each tested, each with an acceptance criterion, on every batch. Impurities above a threshold are not merely counted as area — they must be identified individually.

For synthetic peptides specifically, the FDA's 2021 guidance on abbreviated applications for certain highly purified synthetic peptides set out expectations for identifying and characterising peptide-related impurities^[4].

That guidance is currently in flux. On 28 July 2026 the FDA withdrew the 2021 document, stating it no longer reflects the agency's current scientific thinking, and published revised draft product-specific guidances for a set of peptide products^[5]. Anyone relying on the detail should check the current status directly. Regulatory facts of this kind go stale quickly, and this one is mid-revision.

The contrast that matters is structural, not about any particular threshold. Material sold for research use only sits outside that system entirely. Nothing requires a specification, nothing requires a defined test panel, and nothing requires that the tests which were run be the ones that would catch the problems a given sequence is prone to.

How to read the two numbers on a certificate#

A short checklist, in the order the questions actually arise.

• Is the chromatogram attached, or only the percentage? A number with no trace behind it cannot be checked by anyone. The trace shows peak shape, baseline and whether the main peak looks like one peak.
• What wavelength and what method? Purity figures are only comparable when the conditions are. A percentage with no method is a percentage from an unknown measurement.
• Does the mass result state the observed and expected masses? "Confirmed by MS" is an assertion. Two numbers that match is a result.
• Was the mass measured at high resolution? Deamidation moves the mass by about one dalton. Whether that is visible depends on the instrument.
• Is there a content assay as well? Amino acid analysis or elemental analysis. Purity and identity together still do not weigh the peptide.
• Does the document say what was not tested? The most informative certificates are explicit about scope. Silence is not a pass.

The honest conclusion#

Neither of these tests is weak. Reversed-phase HPLC is a workhorse separation method and mass spectrometry is an extraordinarily precise way to identify a molecule. The problem is never the instruments.

The problem is that two results get printed side by side and read as a single verdict — "pure and confirmed" — when they are two narrow answers to two narrow questions, each with a defined blind spot. Purity does not identify. Identity does not quantify. Neither weighs the peptide, and neither can see a stereochemical error.

Knowing that does not tell you whether any peptide does anything in a living system. It tells you precisely what a certificate of analysis has measured, which is the only thing a certificate was ever capable of telling you.

Where to go next#

• Why a 10 mg peptide vial does not contain 10 mg of peptide — purity is a ratio, content is a mass, and most certificates only report one.
• Peptide purity, contamination, and the limits of a certificate of analysis — what a certificate cannot tell you at all.
• Why peptides degrade: the chemistry behind stability and storage — the same side reactions, happening after the batch was released.
• How to read peptide research without falling for marketing — study types, the animal-to-human gap, and the common tricks.

Advertising disclosure: ads on this page are for NuNu Research, a research-use-only chemical storefront that shares an owner with PeptidesInfo. Ads never influence the evidence grades, regulatory statuses, or conclusions above, which come solely from the cited primary sources.